ALIZE RP Company Profile

11:51 EDT 20th March 2018 | BioPortfolio

News Articles [4 Associated News Articles listed on BioPortfolio]

Alize, Millendo merge to create leading endocrine disease-focused firm

In an effort to become a leader in the endocrine space, Millendo Therapeutics Inc. is acquiring fellow closely held Alize Pharma SAS in a stock swap.

Millendo to acquire Alize, gains Prader-Willi candidate

Millendo Therapeutics Sweeps Up Phase II Asset With Acquisition of Small Biotech

Millendo Therapeutics announced that it has acquired Alize Pharma SAS in a stock-based transaction.

Alize Pharma SAS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15112017] Prices from USD $250

SummaryAlize Pharma SAS Alize Pharma, a subsidiary of Jazz Pharmaceuticals Plc is a biotechnology company that develops biopharmaceutical drugs, proteins and peptides. The company provides unacylated ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "ALIZE RP" on BioPortfolio

We have published hundreds of ALIZE RP news stories on BioPortfolio along with dozens of ALIZE RP Clinical Trials and PubMed Articles about ALIZE RP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ALIZE RP Companies in our database. You can also find out about relevant ALIZE RP Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record